Literature DB >> 8043620

A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium.

H J Koponen1, J Sirviö, U Lepola, E Leinonen, P J Riekkinen.   

Abstract

Cerebrospinal fluid acetylcholinesterase (CSF AChE) was determined for elderly delirious patients during the acute stage and after a 1- and 4-year follow-up periods, and the AChE levels were compared with age-equivalent controls. The AChE levels measured during the index admission correlated with the length of life after delirium, suggesting that cholinergic dysfunction may have prognostic significance in delirious patients. Although the CSF AChE concentrations measured during the index admission were in the same range as in controls, we observed a declining trend in patients with various structural brain diseases during the follow-up period. The decreasing levels may reflect the progression of the underlying dementia in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043620     DOI: 10.1007/bf02195729

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  34 in total

1.  The effect of chlorpromazine on the concentration of acetylcholinesterase in the cerebrospinal fluid of rabbits.

Authors:  S A Greenfield; I W Chubb; A D Smith
Journal:  Neuropharmacology       Date:  1979-02       Impact factor: 5.250

Review 2.  Antemortem markers of Alzheimer's disease.

Authors:  E Hollander; R C Mohs; K L Davis
Journal:  Neurobiol Aging       Date:  1986 Sep-Oct       Impact factor: 4.673

3.  Association of postoperative delirium with raised serum levels of anticholinergic drugs.

Authors:  L E Tune; N F Damlouji; A Holland; T J Gardner; M F Folstein; J T Coyle
Journal:  Lancet       Date:  1981-09-26       Impact factor: 79.321

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.

Authors:  H Soininen; A Pitkänen; T Halonen; P J Riekkinen
Journal:  Acta Neurol Scand       Date:  1984-07       Impact factor: 3.209

6.  Cholinergic-dependent cognitive deficits in Parkinson's disease.

Authors:  B Dubois; F Danzé; B Pillon; G Cusimano; F Lhermitte; Y Agid
Journal:  Ann Neurol       Date:  1987-07       Impact factor: 10.422

7.  Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.

Authors:  L Tune; S Gucker; M Folstein; L Oshida; J T Coyle
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

8.  Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.

Authors:  H Soininen; T Halonen; P J Riekkinen
Journal:  Acta Neurol Scand       Date:  1981-09       Impact factor: 3.209

9.  Neocortical cholinergic neurons in elderly people.

Authors:  P White; C R Hiley; M J Goodhardt; L H Carrasco; J P Keet; I E Williams; D M Bowen
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

10.  Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.

Authors:  J Sirviö; H S Soininen; R Kutvonen; J M Hyttinen; E L Helkala; P J Riekkinen
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.